Protagenic Therapeutics Stock Price Prediction
| PTIXW Stock | USD 0.01 0.03 65.12% |
Momentum 48
Impartial
Oversold | Overbought |
Using Protagenic Therapeutics hype-based prediction, you can estimate the value of Protagenic Therapeutics from the perspective of Protagenic Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Protagenic Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Protagenic because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Protagenic Therapeutics after-hype prediction price | USD 0.0491 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Protagenic | Build AI portfolio with Protagenic Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Protagenic Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Protagenic Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Protagenic Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Protagenic Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Protagenic Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Protagenic Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Protagenic Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Protagenic Therapeutics' historical news coverage. Protagenic Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 34.89, respectively. We have considered Protagenic Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Protagenic Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Protagenic Therapeutics is based on 3 months time horizon.
Protagenic Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Protagenic Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Protagenic Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Protagenic Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
4.25 | 36.19 | 1.36 | 1.09 | 27 Events / Month | 5 Events / Month | In about 27 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.05 | 14.22 |
|
Protagenic Therapeutics Hype Timeline
Protagenic Therapeutics is at this time traded for 0.01. The entity has historical hype elasticity of -1.36, and average elasticity to hype of competition of -1.09. Protagenic is anticipated to increase in value after the next headline, with the price projected to jump to 0.0491 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 14.22%, whereas the daily expected return is at this time at 4.25%. The volatility of related hype on Protagenic Therapeutics is about 14136.72%, with the expected price after the next announcement by competition of -1.08. Protagenic Therapeutics has accumulated 942.76 K in total debt. Protagenic Therapeutics has a current ratio of 1.31, which is within standard range for the sector. Note, when we think about Protagenic Therapeutics' use of debt, we should always consider it together with its cash and equity.Assuming the 90 days horizon the next anticipated press release will be in about 27 days. Check out Protagenic Therapeutics Basic Forecasting Models to cross-verify your projections.Protagenic Therapeutics Related Hype Analysis
Having access to credible news sources related to Protagenic Therapeutics' direct competition is more important than ever and may enhance your ability to predict Protagenic Therapeutics' future price movements. Getting to know how Protagenic Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Protagenic Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BCTXZ | BriaCell Therapeutics Corp | (0.02) | 8 per month | 12.03 | 0 | 17.86 | (17.78) | 69.68 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 0.00 | 0.22 | 20.00 | (1.96) | 68.90 | |
| ELAB | Elevai Labs Common | (2.64) | 4 per month | 0.00 | (0.42) | 5.71 | (14.29) | 38.62 | |
| XRTX | XORTX Therapeutics | (0.01) | 10 per month | 0.00 | (0.06) | 7.14 | (6.15) | 20.83 | |
| ATXI | Avenue Therapeutics | (0.12) | 25 per month | 0.00 | (0.11) | 12.66 | (17.07) | 42.40 | |
| MLEC | Moolec Science SA | (0.21) | 9 per month | 10.55 | 0.03 | 15.63 | (16.33) | 152.55 | |
| WINT | Windtree Therapeutics | 0.01 | 7 per month | 0.00 | (0.21) | 20.00 | (20.00) | 58.33 | |
| VRAX | Virax Biolabs Group | (0.01) | 9 per month | 0.00 | (0.07) | 7.89 | (10.20) | 92.80 | |
| DRMA | Dermata Therapeutics | (0.15) | 9 per month | 0.00 | (0.04) | 16.18 | (12.50) | 37.70 | |
| NCEL | NewcelX | 0.59 | 5 per month | 0.00 | (0.24) | 10.12 | (16.98) | 39.40 |
Protagenic Therapeutics Additional Predictive Modules
Most predictive techniques to examine Protagenic price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Protagenic using various technical indicators. When you analyze Protagenic charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Protagenic Therapeutics Predictive Indicators
The successful prediction of Protagenic Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Protagenic Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Protagenic Therapeutics based on analysis of Protagenic Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Protagenic Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Protagenic Therapeutics's related companies. | 2025 | 2026 (projected) | Payables Turnover | 0.56 | 0.53 | Days Of Inventory On Hand | 269.53 | 277.63 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Additional Tools for Protagenic Stock Analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.